TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 29.3% | 29.6% | 32.3% | 28.0% | 31.5% | 33.1% | 31.1% | 31.0% | 30.9% | 33.6% | 34.5% | 48.9% | |
| 70.7% | 70.4% | 67.7% | 72.0% | 68.5% | 66.9% | 68.9% | 69.0% | 69.1% | 66.4% | 65.5% | 51.1% | |
| 21.5% | 19.1% | 18.0% | 18.4% | 17.6% | 15.0% | 14.3% | 14.7% | 15.7% | 17.1% | 15.9% | 15.0% | |
| 28.1% | 36.0% | 35.7% | 35.5% | 34.2% | 29.3% | 27.4% | 24.8% | 24.8% | 24.7% | 24.1% | 22.7% | |
| 78.0% | 63.1% | 58.7% | 58.3% | 60.9% | 63.8% | 53.0% | 56.1% | 56.9% | 61.4% | 58.0% | 39.1% | |
| -7.3% | 7.2% | 9.0% | 13.7% | 9.8% | 3.1% | 15.9% | 12.9% | 12.2% | 5.0% | 7.5% | 12.0% | |
| 1.8% | 1.8% | 1.3% | 1.8% | 2.3% | 0.0% | 4.1% | 3.4% | 2.9% | 0.0% | 3.0% | 7.9% | |
| -8.2% | 6.7% | 8.3% | 12.3% | 4.5% | -1.8% | 11.5% | 8.5% | 9.3% | 1.2% | 3.8% | 5.8% | |
| -0.1% | 2.1% | 1.6% | 1.7% | -0.7% | -3.2% | -0.3% | 2.0% | 1.4% | -2.1% | 1.5% | 1.5% | |
| -8.2% | 4.4% | 6.6% | 10.6% | 5.2% | 1.3% | 11.8% | 6.4% | 7.9% | 3.4% | 2.4% | 4.3% | |
| 3.2% | 19.4% | 17.1% | 20.3% | 22.1% | 20.4% | 30.8% | 33.2% | 31.9% | 26.8% | 26.4% | 29.7% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.